TACTful Perseverance and a Black Swan Event Tactful Perseverance and a Black Swan Event
–TACT2 to follow-up on post-MI diabetic patients.
“I have to admit that until 1999, I had no particular interest in studying a pariah therapy called EDTA chelation — really just not my style.”
“When the Duke staff distributed the previously blinded analyses, all of us turned to the bottom line, ... more
How Treating the Elephant in the Room Became a Black Swan Event: Toxic Metals and Cardiovascular Disease Gervasio A. Lamas, MD of Mount Sinai Medical Center and Columbia University Medical Center presented at Brigham and Women’s Hospital Cardiovascular Grand Rounds in March 2019. His presentation was titled, “How ... more Chelation for CLI in Diabetic Patients Shows Potential in Small Series Before and after photos presented at 2019 International Symposium on Endovascular Therapy (ISET) show the effect of chelation therapy in diabetic patients with critical limb ischemia (CLI), highlighting its potential ... more Chelation therapy surprises experts with positive results in diabetic patients with CLI An e-poster and presentation at the 31st International Symposium on Endovascular Therapy (ISET) highlighted positive results from a pilot study of edetate disodium-based chelation in diabetic patients with critical limb ischaemia ... more Alternative Heart Medicine Becoming Mainstream Scott Doughty, MD aims to decrease the number heart attacks, strokes, and deaths for individuals through TACT2 and chelation therapy. Dr. Doughty is the startup inspiration behind U.P. Holistic Medicine, ... more Reducing Cardiac Risks for Diabetics through Chelation Therapy Chelation therapy was developed in the 1930s and was designed to remove heavy metals from the blood of severely metal-poisoned patients. In 2012, findings from the Trial to Assess Chelation ... more TACT Research Presented at the American Heart Association’s Scientific Sessions 2018 The Trial to Assess Chelation Therapy (TACT) demonstrated a major improvement in ischemic cardiac events in diabetic patients randomized to edetate disodium-based chelation. Research findings presented at the American Heart ... more Crime of the Century: The Failure to Prevent the Lead Poisoning Pandemic (Video) Clinician-scientist Bruce Lanphear, MD, has produced a video on the lead pandemic: “Over the last century the planet has experienced the largest mass contamination in history, a pandemic of lead ... more Lead could be fueling America’s high blood pressure epidemic There’s one possible reason so many Americans, especially those living in inner cities, have high blood pressure: lead exposure.
Researchers tested people’s bones for evidence they took in lead over the ... more Free download: TACT2 overview with Dr. Gervasio Lamas Learn about the Trial to Assess Chelation Therapy 2 (TACT2) in this free presentation from the study chairman, Dr. Gervasio Lamas. Audio included.
more New study could help decide whether chelation benefits the heart Chelation therapy has long been scorned by many in the medical community. But after a major study suggested it was somewhat effective for heart disease, the alternative health treatment is ... more US deaths from lead exposure 10 times higher than thought, study suggests Lead exposure may be responsible for nearly 10 times more deaths in the United States than previously thought, according to a new study from The Lancet Public Health.
Watch the video ... more What is chelation, and how does it work? Dr. Jeff Baker, of Clinical Research Prime in Idaho Falls, Idaho, explains how removing toxic metals from the body with chelation therapy could help patients with cardiovascular issues. His clinic ... more Free info session on diabetes, heart disease, and TACT2 TACT2 investigator Dr. Richard Nahas will present a free information session on diabetes, heart disease, and the TACT2 study on Tuesday, February 13, 7:00–8:30 p.m., at Ben Franklin Place in ... more Nueva investigación sobre diabetes mira hacia el pasado Los diabéticos Tipo 2 con historial de paro cardíaco pueden encontrar una solución a sus complicaciones. ¿La clave? Una droga desarrollada en la década de 1950.
more To treat diabetes in new ways, TACT2 investigators look to the past Type 2 diabetics with a history of cardiac arrest might find a solution to their complications. The key? A drug developed in the 1950s.
more Chelation therapy: As good as statins, aspirin for your heart? Tact2 investigator Dr. Gervasio Lamas explains how chelation therapy could be a “game changer” in the treatment and prevention of heart disease.
more Little Rock Arkansas: The Arkansas Heart Hospital is participating in TACT2 March 28, 2017
Little Rock, Arkansas: The Arkansas Heart Hospital is now involved in a clinical trial that could lead to a new way to treat heart disease. Jancey Sheets has ... more